ISI Unveils Prestigious Speaker Line-Up for eSolutions Conference in Barcelona
- Keynote address by Dr. Carlos Buesa, CEO, Oryzon Genomics, Vice President of the Spanish Association of Bioenterprises, ASEBIO, and President of the Association of Catalan Biotechnology Companies, CataloniaBIO
- Executives from Cellerix, GlaxoSmithKline, Sanofi-Aventis and AstraZeneca headline Barcelona program, offering unprecedented access to experts on today’s most challenging regulatory issues
Eschborn, Germany (August 10, 2009) Image Solutions Inc. (ISI), a leading provider of electronic submissions management and publishing solutions for the life sciences industry, has unveiled a prestigious line-up of speakers for its annual eSolutions Conference in Barcelona, Spain, this September to support an agenda aimed at reinventing the regulatory function.
The ISI eSolutions Conference, now in its seventh year, takes place on September 29 – 30 at the Spanish city’s Hotel Arts, following the theme, “Accelerating Change in the New R&D Paradigm”.
The annual event is one of the most recognized dates in the calendar for senior-level pharmaceutical executives looking to share ideas with peers, build partnerships with industry thought leaders, and hear from key experts on how they are addressing some of their most pressing challenges.
Those attending in Barcelona this September can look forward to an informative program, with a keynote address from Dr. Carlos Buesa, Chief Executive Officer of Oryzon Genomics, one of the fastest-growing biotech companies in Spain. Dr. Buesa also serves as vice president of the Spanish biotechnology association, ASEBIO, president of the Association of Catalan Biotechnology Companies (CataloniaBio), and he is a member of the governing body of the Executive Committee of BioRegió de Catalunya, a new regional development model aimed at improving the biotechnology cluster in Catalonia. Dr. Buesa also sits on the boards of other leading biotech companies.
Dr. Buesa got his PhD in Biochemistry from the University of Barcelona, Spain. He has produced more than thirty papers and patents. He developed most of his scientific career in the Pharmacy Faculty at the University of Barcelona. After his PhD, he was awarded an EU post-doctoral fellowship with the Faculty of Medicine at the University of Ghent in Belgium where later he became Senior Investigator with the Flemish Institute of Biotechnology (VIB).
The program will also provide a forum for a series of candid insights from the coalface, with case studies and presentations from high-profile executives, including:
- David Licht, Senior Director of Global Regulatory & Safety Operations, Allergan
- Meredith Purcell, Associate Director, Global Regulatory Publishing, Allergan
- Ulf Klingnäs, Submission Manager, AstraZeneca
- Craig Funt, Executive Director, Acquisition, Collaboration and Information Services, Bristol-Myers Squibb
- María Pascual, Director of Regulatory Affairs, Cellerix
- Todd Gerig, Technology Integrator, Eli Lilly
- Vicki Phelan, Pharmaceutical Managing Director, EquaTerra
- Stephen Hasler, VP, Regulatory Operations, GlaxoSmithKline
- Bill Snyder, Director, Information and Records Management, Pfizer
- Dr. Geoffrey Williams, e-Regulatory Liaison, Roche
- Graham Shelvey, Senior Director Worldwide Regulatory Operations, Sanofi-Aventis
- Joel Alvarez, Associate Director, Global Regulatory Operations, Shire HGT Inc.
- Tracy Baldwin, EU Regulatory Operations, Takeda
- Janis Gyzen, Assistant Director Submission Programs, Takeda
- Rick Lilley, VP, Global Regulatory Affairs at UCB Pharma
Why Attend?
2009 is set to redefine the structure and dynamics of the pharmaceutical industry in a way not seen since the beginning of this decade. With increased competition, reduced resources, and financial constraints, many life science companies are seeking to reengineer current research and development practices in order to support increased regulatory requirements and complexity; expanded co-development collaboration; and a rapidly changing product development model.
The 2009 program will incorporate more intimate panel and think-tank style discussions, interactive exchanges with Q&A sessions, alongside the main keynote speeches. The conference agenda will cover the following topics:
- Outsourcing to improve productivity and gain competitive advantage;
- Regulatory information management;
- Consolidating pipelines and submission strategies in an age of mergers, acquisitions, and other types of collaborative partnerships;
- The status and implications of electronic submissions in emerging and expanding markets, such as the BRIC nations.
The pre-conference Regulatory Update Working Session will discuss the progress that has been achieved by regulatory authorities in the three regions of the International Conference on Harmonisation (ICH) and beyond as well as the implications for companies filing submissions in those regions. Speakers will also cover the latest in EMEA progress toward adoption of the electronic Common Technical Document (eCTD) as well as the evolving non-eCTD electronic submission (NeeS) standard.
Event details
ISI’s 7th Annual eSolutions Conference: Accelerating Change in the New R&D Paradigm
Dates
Pre-conference Regulatory Update Working Session on eCTD: Mon, September 28, 12:00 – 4:00 Tuesday, September 29 – Wednesday, September 30, 2009
Venue
Hotel Arts Barcelona
Marina 19-21
Barcelona 8005 Spain
Phone: 34 93 221 10 00
Fax: 34 93 221 10 70
Registration
To register for the conference and/or make a hotel reservation please visit http://www.imagesolutions.com/eSolutionsBarcelona